Hjem › Hjerteanfald › Missouri
Hjerteanfald kliniske forsøg i Missouri
3 studier for Hjerteanfald søger deltagere på steder i Missouri.
Officiel studietekst (engelsk)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Clinical Research Consultants, Kansas City
- Kansas City VA Medical Center, Kansas City
- DCI-Rockhill, Kansas City
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- StudyMetrix Research, City of Saint Peters
- Washington Univ School Of Medicine, St Louis
- Mercy Hospital St Louis, St Louis
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 4. sep. 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Sisters of Saint Mary Health Heart and Vascular Care, Bridgeton
- Kansas City Veterans Affairs Medical Center, Kansas City
- Washington University, St Louis
RekruttererFase 3
Alder 50 til 105 · Alle køn · Opdateret 21. aug. 2026 · NCT07136012Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.